BioLizard joins BioWin
Ghent, 7th February 2024. We are pleased to announce that BioLizard has joined BioWin, the health cluster in Wallonia, Belgium. BioWin is the regional reference for all stakeholders in health, biotech and medtech research, and innovation projects. It currently...
BioLizard announces the appointment of André van de Sande as Chairman of the Board
Ghent (Belgium), January 30, 2024 – BioLizard is pleased to announce the appointment of André van de Sande as the new Chair of our Board of Directors. As a Senior Executive with 30 years of life sciences experience and a track record in both...
BioLizard announces Swiss subsidiary and service offering for AI-powered digital transformation of life sciences at Biopôle in Lausanne
Lausanne (Switzerland) and Ghent (Belgium), 23rd January 2024 – Today we are proud to announce the incorporation of BioLizard SA and the opening of new offices at Biopôle in Lausanne, home to one of the largest biotech hubs in Switzerland. With...
BioLizard and Parean Biotechnologies announce partnership
Parean Biotechnologies’ cutting edge technologies for deciphering the immune system complements BioLizard’s tailored advanced analytics services. Ghent, Belgium October 30th, 2023. Parean Biotechnologies and BioLizard announced their partnership. Parean...